Loading…
Functional metagenomic and metabolomics analysis of gut dysbiosis induced by hyperoxia
Inhaled oxygen is the first-line therapeutic approach for maintaining tissue oxygenation in critically ill patients, but usually exposes patients to damaging hyperoxia. Hyperoxia adversely increases the oxygen tension in the gut lumen which harbors the trillions of microorganisms playing an importan...
Saved in:
Published in: | Frontiers in microbiology 2023-09, Vol.14, p.1197970-1197970 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c469t-81ace0fa1c066995fb4273542098d30f3a01541c365fc38b3200951bd6649a983 |
---|---|
cites | cdi_FETCH-LOGICAL-c469t-81ace0fa1c066995fb4273542098d30f3a01541c365fc38b3200951bd6649a983 |
container_end_page | 1197970 |
container_issue | |
container_start_page | 1197970 |
container_title | Frontiers in microbiology |
container_volume | 14 |
creator | Cai, Yulan Luo, Yanhong Dai, Ninan Yang, Yan He, Ying Chen, Huajun Zhao, Manlu Fu, Xiaoyun Chen, Tao Xing, Zhouxiong |
description | Inhaled oxygen is the first-line therapeutic approach for maintaining tissue oxygenation in critically ill patients, but usually exposes patients to damaging hyperoxia. Hyperoxia adversely increases the oxygen tension in the gut lumen which harbors the trillions of microorganisms playing an important role in host metabolism and immunity. Nevertheless, the effects of hyperoxia on gut microbiome and metabolome remain unclear, and metagenomic and metabolomics analysis were performed in this mouse study.
C57BL/6 mice were randomly divided into a control (CON) group exposed to room air with fractional inspired oxygen (FiO
) of 21% and a hyperoxia (OXY) group exposed to FiO
of 80% for 7 days, respectively. Fecal pellets were collected on day 7 and subjected to metagenomic sequencing. Another experiment with the same design was performed to explore the impact of hyperoxia on gut and serum metabolome. Fecal pellets and blood were collected and high-performance liquid chromatography with mass spectrometric analysis was carried out.
At the phylum level, hyperoxia increased the ratio of
(
= 0.049). At the species level, hyperoxia reduced the abundance of
(
= 0.007),
(
= 0.010), and
(
= 0.011)
. Linear discriminant analysis effect size (LEfSe) revealed that
and
, both belonging to
, were the marker microbes of the CON group, while
was the marker microbes of the OXY group. Metagenomic analysis using Kyoto Encyclopedia of Genes and Genomes (KEGG) and Carbohydrate-Active enZYmes (CAZy) revealed that hyperoxia provoked disturbances in carbohydrate and lipid metabolism. Fecal metabolomics analysis showed hyperoxia reduced 11-dehydro Thromboxane B2-d4 biosynthesis (
= 1.10 × 10
). Hyperoxia blunted fecal linoleic acid metabolism (
= 0.008) and alpha-linolenic acid metabolism (
= 0.014). We showed that 1-docosanoyl-glycer-3-phosphate (
= 1.58 × 10
) was the most significant differential serum metabolite inhibited by hyperoxia. In addition, hyperoxia suppressed serum hypoxia-inducible factor-1 (HIF-1,
= 0.007) and glucagon signaling pathways (
= 0.007).
Hyperoxia leads to gut dysbiosis by eliminating beneficial and oxygen strictly intolerant
with genomic dysfunction of carbohydrate and lipid metabolism. In addition, hyperoxia suppresses unsaturated fatty acid metabolism in the gut and inhibits the HIF-1 and glucagon signaling pathways in the serum. |
doi_str_mv | 10.3389/fmicb.2023.1197970 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_c756ac3f67ff4434b416254654654bcf</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_c756ac3f67ff4434b416254654654bcf</doaj_id><sourcerecordid>2878017369</sourcerecordid><originalsourceid>FETCH-LOGICAL-c469t-81ace0fa1c066995fb4273542098d30f3a01541c365fc38b3200951bd6649a983</originalsourceid><addsrcrecordid>eNpVkU1PHSEUhklTU436B1w0s-zmXoHDwLBqGtPbmpi4UeOOAANXzMxwCzON8-_lfmiUEOC8nPNwyIvQBcFLgEZe-j5Ys6SYwpIQKaTAX9AJ4ZwtANPHrx_Ox-g852dcBsO0rN_QMYiGYQH4BD2spsGOIQ66q3o36rUbYiFXemh3sYndNs5F0N2cQ66ir9bTWLVzNiFuhTC0k3VtZebqad64FF-CPkNHXnfZnR_2U3S_-n139Xdxc_vn-urXzcIyLsdFQ7R12GtiMedS1t4wKqBmFMumBexBY1IzYoHX3kJjoPQva2La8jepZQOn6HrPbaN-VpsUep1mFXVQOyGmtdJpDLZzyoqaawueC-8ZA2YY4bRmfDeN9YX1c8_aTKZ3rXXDmHT3Cfr5ZghPah3_K4JrLhmFQvhxIKT4b3J5VH3I1nWdHlycsqKNaDARwGVJpftUm2LOyfn3dwhWW4PVzmC1NVgdDC5F3z92-F7yZie8AuJuorg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2878017369</pqid></control><display><type>article</type><title>Functional metagenomic and metabolomics analysis of gut dysbiosis induced by hyperoxia</title><source>Open Access: PubMed Central</source><creator>Cai, Yulan ; Luo, Yanhong ; Dai, Ninan ; Yang, Yan ; He, Ying ; Chen, Huajun ; Zhao, Manlu ; Fu, Xiaoyun ; Chen, Tao ; Xing, Zhouxiong</creator><creatorcontrib>Cai, Yulan ; Luo, Yanhong ; Dai, Ninan ; Yang, Yan ; He, Ying ; Chen, Huajun ; Zhao, Manlu ; Fu, Xiaoyun ; Chen, Tao ; Xing, Zhouxiong</creatorcontrib><description>Inhaled oxygen is the first-line therapeutic approach for maintaining tissue oxygenation in critically ill patients, but usually exposes patients to damaging hyperoxia. Hyperoxia adversely increases the oxygen tension in the gut lumen which harbors the trillions of microorganisms playing an important role in host metabolism and immunity. Nevertheless, the effects of hyperoxia on gut microbiome and metabolome remain unclear, and metagenomic and metabolomics analysis were performed in this mouse study.
C57BL/6 mice were randomly divided into a control (CON) group exposed to room air with fractional inspired oxygen (FiO
) of 21% and a hyperoxia (OXY) group exposed to FiO
of 80% for 7 days, respectively. Fecal pellets were collected on day 7 and subjected to metagenomic sequencing. Another experiment with the same design was performed to explore the impact of hyperoxia on gut and serum metabolome. Fecal pellets and blood were collected and high-performance liquid chromatography with mass spectrometric analysis was carried out.
At the phylum level, hyperoxia increased the ratio of
(
= 0.049). At the species level, hyperoxia reduced the abundance of
(
= 0.007),
(
= 0.010), and
(
= 0.011)
. Linear discriminant analysis effect size (LEfSe) revealed that
and
, both belonging to
, were the marker microbes of the CON group, while
was the marker microbes of the OXY group. Metagenomic analysis using Kyoto Encyclopedia of Genes and Genomes (KEGG) and Carbohydrate-Active enZYmes (CAZy) revealed that hyperoxia provoked disturbances in carbohydrate and lipid metabolism. Fecal metabolomics analysis showed hyperoxia reduced 11-dehydro Thromboxane B2-d4 biosynthesis (
= 1.10 × 10
). Hyperoxia blunted fecal linoleic acid metabolism (
= 0.008) and alpha-linolenic acid metabolism (
= 0.014). We showed that 1-docosanoyl-glycer-3-phosphate (
= 1.58 × 10
) was the most significant differential serum metabolite inhibited by hyperoxia. In addition, hyperoxia suppressed serum hypoxia-inducible factor-1 (HIF-1,
= 0.007) and glucagon signaling pathways (
= 0.007).
Hyperoxia leads to gut dysbiosis by eliminating beneficial and oxygen strictly intolerant
with genomic dysfunction of carbohydrate and lipid metabolism. In addition, hyperoxia suppresses unsaturated fatty acid metabolism in the gut and inhibits the HIF-1 and glucagon signaling pathways in the serum.</description><identifier>ISSN: 1664-302X</identifier><identifier>EISSN: 1664-302X</identifier><identifier>DOI: 10.3389/fmicb.2023.1197970</identifier><identifier>PMID: 37840730</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>gut dysbiosis ; gut metabolome ; gut microbiome ; hyperoxia ; metagenomic sequencing ; Microbiology ; serum metabolome</subject><ispartof>Frontiers in microbiology, 2023-09, Vol.14, p.1197970-1197970</ispartof><rights>Copyright © 2023 Cai, Luo, Dai, Yang, He, Chen, Zhao, Fu, Chen and Xing.</rights><rights>Copyright © 2023 Cai, Luo, Dai, Yang, He, Chen, Zhao, Fu, Chen and Xing. 2023 Cai, Luo, Dai, Yang, He, Chen, Zhao, Fu, Chen and Xing</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c469t-81ace0fa1c066995fb4273542098d30f3a01541c365fc38b3200951bd6649a983</citedby><cites>FETCH-LOGICAL-c469t-81ace0fa1c066995fb4273542098d30f3a01541c365fc38b3200951bd6649a983</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569423/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569423/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27900,27901,53765,53767</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37840730$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cai, Yulan</creatorcontrib><creatorcontrib>Luo, Yanhong</creatorcontrib><creatorcontrib>Dai, Ninan</creatorcontrib><creatorcontrib>Yang, Yan</creatorcontrib><creatorcontrib>He, Ying</creatorcontrib><creatorcontrib>Chen, Huajun</creatorcontrib><creatorcontrib>Zhao, Manlu</creatorcontrib><creatorcontrib>Fu, Xiaoyun</creatorcontrib><creatorcontrib>Chen, Tao</creatorcontrib><creatorcontrib>Xing, Zhouxiong</creatorcontrib><title>Functional metagenomic and metabolomics analysis of gut dysbiosis induced by hyperoxia</title><title>Frontiers in microbiology</title><addtitle>Front Microbiol</addtitle><description>Inhaled oxygen is the first-line therapeutic approach for maintaining tissue oxygenation in critically ill patients, but usually exposes patients to damaging hyperoxia. Hyperoxia adversely increases the oxygen tension in the gut lumen which harbors the trillions of microorganisms playing an important role in host metabolism and immunity. Nevertheless, the effects of hyperoxia on gut microbiome and metabolome remain unclear, and metagenomic and metabolomics analysis were performed in this mouse study.
C57BL/6 mice were randomly divided into a control (CON) group exposed to room air with fractional inspired oxygen (FiO
) of 21% and a hyperoxia (OXY) group exposed to FiO
of 80% for 7 days, respectively. Fecal pellets were collected on day 7 and subjected to metagenomic sequencing. Another experiment with the same design was performed to explore the impact of hyperoxia on gut and serum metabolome. Fecal pellets and blood were collected and high-performance liquid chromatography with mass spectrometric analysis was carried out.
At the phylum level, hyperoxia increased the ratio of
(
= 0.049). At the species level, hyperoxia reduced the abundance of
(
= 0.007),
(
= 0.010), and
(
= 0.011)
. Linear discriminant analysis effect size (LEfSe) revealed that
and
, both belonging to
, were the marker microbes of the CON group, while
was the marker microbes of the OXY group. Metagenomic analysis using Kyoto Encyclopedia of Genes and Genomes (KEGG) and Carbohydrate-Active enZYmes (CAZy) revealed that hyperoxia provoked disturbances in carbohydrate and lipid metabolism. Fecal metabolomics analysis showed hyperoxia reduced 11-dehydro Thromboxane B2-d4 biosynthesis (
= 1.10 × 10
). Hyperoxia blunted fecal linoleic acid metabolism (
= 0.008) and alpha-linolenic acid metabolism (
= 0.014). We showed that 1-docosanoyl-glycer-3-phosphate (
= 1.58 × 10
) was the most significant differential serum metabolite inhibited by hyperoxia. In addition, hyperoxia suppressed serum hypoxia-inducible factor-1 (HIF-1,
= 0.007) and glucagon signaling pathways (
= 0.007).
Hyperoxia leads to gut dysbiosis by eliminating beneficial and oxygen strictly intolerant
with genomic dysfunction of carbohydrate and lipid metabolism. In addition, hyperoxia suppresses unsaturated fatty acid metabolism in the gut and inhibits the HIF-1 and glucagon signaling pathways in the serum.</description><subject>gut dysbiosis</subject><subject>gut metabolome</subject><subject>gut microbiome</subject><subject>hyperoxia</subject><subject>metagenomic sequencing</subject><subject>Microbiology</subject><subject>serum metabolome</subject><issn>1664-302X</issn><issn>1664-302X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkU1PHSEUhklTU436B1w0s-zmXoHDwLBqGtPbmpi4UeOOAANXzMxwCzON8-_lfmiUEOC8nPNwyIvQBcFLgEZe-j5Ys6SYwpIQKaTAX9AJ4ZwtANPHrx_Ox-g852dcBsO0rN_QMYiGYQH4BD2spsGOIQ66q3o36rUbYiFXemh3sYndNs5F0N2cQ66ir9bTWLVzNiFuhTC0k3VtZebqad64FF-CPkNHXnfZnR_2U3S_-n139Xdxc_vn-urXzcIyLsdFQ7R12GtiMedS1t4wKqBmFMumBexBY1IzYoHX3kJjoPQva2La8jepZQOn6HrPbaN-VpsUep1mFXVQOyGmtdJpDLZzyoqaawueC-8ZA2YY4bRmfDeN9YX1c8_aTKZ3rXXDmHT3Cfr5ZghPah3_K4JrLhmFQvhxIKT4b3J5VH3I1nWdHlycsqKNaDARwGVJpftUm2LOyfn3dwhWW4PVzmC1NVgdDC5F3z92-F7yZie8AuJuorg</recordid><startdate>20230928</startdate><enddate>20230928</enddate><creator>Cai, Yulan</creator><creator>Luo, Yanhong</creator><creator>Dai, Ninan</creator><creator>Yang, Yan</creator><creator>He, Ying</creator><creator>Chen, Huajun</creator><creator>Zhao, Manlu</creator><creator>Fu, Xiaoyun</creator><creator>Chen, Tao</creator><creator>Xing, Zhouxiong</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20230928</creationdate><title>Functional metagenomic and metabolomics analysis of gut dysbiosis induced by hyperoxia</title><author>Cai, Yulan ; Luo, Yanhong ; Dai, Ninan ; Yang, Yan ; He, Ying ; Chen, Huajun ; Zhao, Manlu ; Fu, Xiaoyun ; Chen, Tao ; Xing, Zhouxiong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c469t-81ace0fa1c066995fb4273542098d30f3a01541c365fc38b3200951bd6649a983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>gut dysbiosis</topic><topic>gut metabolome</topic><topic>gut microbiome</topic><topic>hyperoxia</topic><topic>metagenomic sequencing</topic><topic>Microbiology</topic><topic>serum metabolome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cai, Yulan</creatorcontrib><creatorcontrib>Luo, Yanhong</creatorcontrib><creatorcontrib>Dai, Ninan</creatorcontrib><creatorcontrib>Yang, Yan</creatorcontrib><creatorcontrib>He, Ying</creatorcontrib><creatorcontrib>Chen, Huajun</creatorcontrib><creatorcontrib>Zhao, Manlu</creatorcontrib><creatorcontrib>Fu, Xiaoyun</creatorcontrib><creatorcontrib>Chen, Tao</creatorcontrib><creatorcontrib>Xing, Zhouxiong</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DAOJ: Directory of Open Access Journals</collection><jtitle>Frontiers in microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cai, Yulan</au><au>Luo, Yanhong</au><au>Dai, Ninan</au><au>Yang, Yan</au><au>He, Ying</au><au>Chen, Huajun</au><au>Zhao, Manlu</au><au>Fu, Xiaoyun</au><au>Chen, Tao</au><au>Xing, Zhouxiong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Functional metagenomic and metabolomics analysis of gut dysbiosis induced by hyperoxia</atitle><jtitle>Frontiers in microbiology</jtitle><addtitle>Front Microbiol</addtitle><date>2023-09-28</date><risdate>2023</risdate><volume>14</volume><spage>1197970</spage><epage>1197970</epage><pages>1197970-1197970</pages><issn>1664-302X</issn><eissn>1664-302X</eissn><abstract>Inhaled oxygen is the first-line therapeutic approach for maintaining tissue oxygenation in critically ill patients, but usually exposes patients to damaging hyperoxia. Hyperoxia adversely increases the oxygen tension in the gut lumen which harbors the trillions of microorganisms playing an important role in host metabolism and immunity. Nevertheless, the effects of hyperoxia on gut microbiome and metabolome remain unclear, and metagenomic and metabolomics analysis were performed in this mouse study.
C57BL/6 mice were randomly divided into a control (CON) group exposed to room air with fractional inspired oxygen (FiO
) of 21% and a hyperoxia (OXY) group exposed to FiO
of 80% for 7 days, respectively. Fecal pellets were collected on day 7 and subjected to metagenomic sequencing. Another experiment with the same design was performed to explore the impact of hyperoxia on gut and serum metabolome. Fecal pellets and blood were collected and high-performance liquid chromatography with mass spectrometric analysis was carried out.
At the phylum level, hyperoxia increased the ratio of
(
= 0.049). At the species level, hyperoxia reduced the abundance of
(
= 0.007),
(
= 0.010), and
(
= 0.011)
. Linear discriminant analysis effect size (LEfSe) revealed that
and
, both belonging to
, were the marker microbes of the CON group, while
was the marker microbes of the OXY group. Metagenomic analysis using Kyoto Encyclopedia of Genes and Genomes (KEGG) and Carbohydrate-Active enZYmes (CAZy) revealed that hyperoxia provoked disturbances in carbohydrate and lipid metabolism. Fecal metabolomics analysis showed hyperoxia reduced 11-dehydro Thromboxane B2-d4 biosynthesis (
= 1.10 × 10
). Hyperoxia blunted fecal linoleic acid metabolism (
= 0.008) and alpha-linolenic acid metabolism (
= 0.014). We showed that 1-docosanoyl-glycer-3-phosphate (
= 1.58 × 10
) was the most significant differential serum metabolite inhibited by hyperoxia. In addition, hyperoxia suppressed serum hypoxia-inducible factor-1 (HIF-1,
= 0.007) and glucagon signaling pathways (
= 0.007).
Hyperoxia leads to gut dysbiosis by eliminating beneficial and oxygen strictly intolerant
with genomic dysfunction of carbohydrate and lipid metabolism. In addition, hyperoxia suppresses unsaturated fatty acid metabolism in the gut and inhibits the HIF-1 and glucagon signaling pathways in the serum.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>37840730</pmid><doi>10.3389/fmicb.2023.1197970</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1664-302X |
ispartof | Frontiers in microbiology, 2023-09, Vol.14, p.1197970-1197970 |
issn | 1664-302X 1664-302X |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_c756ac3f67ff4434b416254654654bcf |
source | Open Access: PubMed Central |
subjects | gut dysbiosis gut metabolome gut microbiome hyperoxia metagenomic sequencing Microbiology serum metabolome |
title | Functional metagenomic and metabolomics analysis of gut dysbiosis induced by hyperoxia |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-25T12%3A08%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Functional%20metagenomic%20and%20metabolomics%20analysis%20of%20gut%20dysbiosis%20induced%20by%20hyperoxia&rft.jtitle=Frontiers%20in%20microbiology&rft.au=Cai,%20Yulan&rft.date=2023-09-28&rft.volume=14&rft.spage=1197970&rft.epage=1197970&rft.pages=1197970-1197970&rft.issn=1664-302X&rft.eissn=1664-302X&rft_id=info:doi/10.3389/fmicb.2023.1197970&rft_dat=%3Cproquest_doaj_%3E2878017369%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c469t-81ace0fa1c066995fb4273542098d30f3a01541c365fc38b3200951bd6649a983%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2878017369&rft_id=info:pmid/37840730&rfr_iscdi=true |